MedPath

spark in seborrheic keratosis. Effect of cryotherapy in treatment of seborrheic keratosis

Phase 2
Conditions
seborrheic keratosis.
Other seborrheic keratosis
L82.1
Registration Number
IRCT20200929048882N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
54
Inclusion Criteria

Patients over 18 years of age
At least 4 lesions

Exclusion Criteria

Lesions in areas under pressure of the body

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PLA) scale, which is a proprietary,validated, 4-ordinal number scale (0, clear [no visibleSKs]; 1, nearly clear; 2, a thin SK 1 mm or less indepth; and, 3, a thick SK more than 1 mm in depth)developed to quantify the effect treatment of the SK. Timepoint: Four visits will be evaluated three weeks apart at the end of day 84. Method of measurement: observation of dermatologist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath